CD8A and neoplasm: In fact, the preventive tumor immunotherapy at early stage of tumor development or for preventing tumor recurrence could induce the formation of a tumor microenvironment (TME), which is conducive to the DC activation as well as the recruitment and activation of the effector immune cells, particularly CD8+ T cells and NK cells (27).